Maintenance Therapy for Recurrent Advanced Ovarian Cancer

Expanding the Treatment Landscape for Recurrent Low-Grade Serous Ovarian CancerПодробнее

Maintenance Therapy in Advanced Ovarian Cancer (2024)Подробнее

Immunotherapy, Novel Therapies, and Shared Decision-Making in Advanced Endometrial CancerПодробнее

Clinical decision making with immunotherapies in advanced or recurrent endometrial cancerПодробнее

Ovarian Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the C...Подробнее

Recurrent Ovarian Cancer (2023)Подробнее

Maintenace Therapy for Advanced Ovarian CancerПодробнее

Treatment Advances in Ovarian Cancer RecurrenceПодробнее

Ovarian Cancer Treatments, Research and Survivorship Updates 2022Подробнее

Recurrent Ovarian Cancer (2022)Подробнее

Advanced Ovarian Cancer: Making the Most of Mutations and Biomarkers to Inform Treatment PlansПодробнее

Updates in the Treatment of Ovarian CancerПодробнее

Maintenance Therapy in Platinum Resistant and Platinum Sensitive Ovarian CancerПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Advanced Ovarian Cancer: New Insights on Making the Most of Mutations and Biomarkers to InformПодробнее

Advanced Ovarian Cancer: Making the Most of Mutations and Biomarkers to Inform Treatment PlansПодробнее

Latest updates in low grade serous ovarian cancer treatment and researchПодробнее

ovarian cancer 2021: Recent advance in treatmentПодробнее

The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP InhibitorsПодробнее

Updates in Treatment of Ovarian Cancer: PARP InhibitorsПодробнее